38
https://pubmed.ncbi.nlm.nih.gov/38091828
This study identifies and validates eight prognostic cuproptosis modulators as promising biomarkers for ankylosing spondylitis, and reveals distinct immune landscapes associated with different cuproptosis patterns in patients.